Gastric Cancer-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583965, encodeId=9b6758396532, content=老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., beContent=nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c002335043, createdName=1227ad64m36暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582852, encodeId=6ac958285252, content=我想问一下，送审的话，状态还是under review吗？还是说会改变？asp 2019-02-21 18:52:00 发表: 投了一篇，大修后接受，编辑审稿人效率高。, beContent=asp 2019-02-21 18:52:00 发表: 投了一篇，大修后接受，编辑审稿人效率高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6715139146, createdName=146715bem82(暂无昵称), createdTime=Tue Jan 07 00:00:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567070, encodeId=640556e07089, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，大修后接受，编辑审稿人效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJMC3tF03dm1t2TEOSN9Hiba2iagxaIW7O4RMcQJEESwLxBY5sgv2v1eyXOZd0e7xng6eLxqp7PoSAw/132, createdBy=c2d31631094, createdName=asp, createdTime=Thu Feb 21 18:52:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]

2023-04-09 146afc57m84暂无昵称来自江苏省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：分子;肿瘤;基础
经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。
编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。
目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。

162 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583965, encodeId=9b6758396532, content=老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., beContent=nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c002335043, createdName=1227ad64m36暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582852, encodeId=6ac958285252, content=我想问一下，送审的话，状态还是under review吗？还是说会改变？asp 2019-02-21 18:52:00 发表: 投了一篇，大修后接受，编辑审稿人效率高。, beContent=asp 2019-02-21 18:52:00 发表: 投了一篇，大修后接受，编辑审稿人效率高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6715139146, createdName=146715bem82(暂无昵称), createdTime=Tue Jan 07 00:00:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567070, encodeId=640556e07089, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，大修后接受，编辑审稿人效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJMC3tF03dm1t2TEOSN9Hiba2iagxaIW7O4RMcQJEESwLxBY5sgv2v1eyXOZd0e7xng6eLxqp7PoSAw/132, createdBy=c2d31631094, createdName=asp, createdTime=Thu Feb 21 18:52:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]

2019-02-03 ms9688259418763462

审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。

158 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583965, encodeId=9b6758396532, content=老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., beContent=nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c002335043, createdName=1227ad64m36暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582852, encodeId=6ac958285252, content=我想问一下，送审的话，状态还是under review吗？还是说会改变？asp 2019-02-21 18:52:00 发表: 投了一篇，大修后接受，编辑审稿人效率高。, beContent=asp 2019-02-21 18:52:00 发表: 投了一篇，大修后接受，编辑审稿人效率高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6715139146, createdName=146715bem82(暂无昵称), createdTime=Tue Jan 07 00:00:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567070, encodeId=640556e07089, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，大修后接受，编辑审稿人效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJMC3tF03dm1t2TEOSN9Hiba2iagxaIW7O4RMcQJEESwLxBY5sgv2v1eyXOZd0e7xng6eLxqp7PoSAw/132, createdBy=c2d31631094, createdName=asp, createdTime=Thu Feb 21 18:52:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]

2020-02-18 148249d5m16暂无昵称

打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表:
你好，请问你的certification form 怎么填写的啊

150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊

207 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583965, encodeId=9b6758396532, content=老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., beContent=nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c002335043, createdName=1227ad64m36暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582852, encodeId=6ac958285252, content=我想问一下，送审的话，状态还是under review吗？还是说会改变？asp 2019-02-21 18:52:00 发表: 投了一篇，大修后接受，编辑审稿人效率高。, beContent=asp 2019-02-21 18:52:00 发表: 投了一篇，大修后接受，编辑审稿人效率高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6715139146, createdName=146715bem82(暂无昵称), createdTime=Tue Jan 07 00:00:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567070, encodeId=640556e07089, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，大修后接受，编辑审稿人效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJMC3tF03dm1t2TEOSN9Hiba2iagxaIW7O4RMcQJEESwLxBY5sgv2v1eyXOZd0e7xng6eLxqp7PoSAw/132, createdBy=c2d31631094, createdName=asp, createdTime=Thu Feb 21 18:52:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]

2020-01-29 1227ad64m36暂无昵称

老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表:
投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快.

nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快.

159 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583965, encodeId=9b6758396532, content=老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., beContent=nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c002335043, createdName=1227ad64m36暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582852, encodeId=6ac958285252, content=我想问一下，送审的话，状态还是under review吗？还是说会改变？asp 2019-02-21 18:52:00 发表: 投了一篇，大修后接受，编辑审稿人效率高。, beContent=asp 2019-02-21 18:52:00 发表: 投了一篇，大修后接受，编辑审稿人效率高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6715139146, createdName=146715bem82(暂无昵称), createdTime=Tue Jan 07 00:00:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567070, encodeId=640556e07089, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，大修后接受，编辑审稿人效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJMC3tF03dm1t2TEOSN9Hiba2iagxaIW7O4RMcQJEESwLxBY5sgv2v1eyXOZd0e7xng6eLxqp7PoSAw/132, createdBy=c2d31631094, createdName=asp, createdTime=Thu Feb 21 18:52:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]

2022-08-10 cyfy1112@163.com

审稿速度:1.0 | 投稿命中率:75.0
经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~
很有效率

103 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583965, encodeId=9b6758396532, content=老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., beContent=nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c002335043, createdName=1227ad64m36暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582852, encodeId=6ac958285252, content=我想问一下，送审的话，状态还是under review吗？还是说会改变？asp 2019-02-21 18:52:00 发表: 投了一篇，大修后接受，编辑审稿人效率高。, beContent=asp 2019-02-21 18:52:00 发表: 投了一篇，大修后接受，编辑审稿人效率高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6715139146, createdName=146715bem82(暂无昵称), createdTime=Tue Jan 07 00:00:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567070, encodeId=640556e07089, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，大修后接受，编辑审稿人效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJMC3tF03dm1t2TEOSN9Hiba2iagxaIW7O4RMcQJEESwLxBY5sgv2v1eyXOZd0e7xng6eLxqp7PoSAw/132, createdBy=c2d31631094, createdName=asp, createdTime=Thu Feb 21 18:52:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]

2019-05-09 120cc505m10(暂无昵称)

它收纳肝癌相关的文章吗？

155 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583965, encodeId=9b6758396532, content=老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., beContent=nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c002335043, createdName=1227ad64m36暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582852, encodeId=6ac958285252, content=我想问一下，送审的话，状态还是under review吗？还是说会改变？asp 2019-02-21 18:52:00 发表: 投了一篇，大修后接受，编辑审稿人效率高。, beContent=asp 2019-02-21 18:52:00 发表: 投了一篇，大修后接受，编辑审稿人效率高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6715139146, createdName=146715bem82(暂无昵称), createdTime=Tue Jan 07 00:00:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567070, encodeId=640556e07089, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，大修后接受，编辑审稿人效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJMC3tF03dm1t2TEOSN9Hiba2iagxaIW7O4RMcQJEESwLxBY5sgv2v1eyXOZd0e7xng6eLxqp7PoSAw/132, createdBy=c2d31631094, createdName=asp, createdTime=Thu Feb 21 18:52:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]

2022-01-08 ms6000000933123975

大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。

115 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583965, encodeId=9b6758396532, content=老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., beContent=nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c002335043, createdName=1227ad64m36暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582852, encodeId=6ac958285252, content=我想问一下，送审的话，状态还是under review吗？还是说会改变？asp 2019-02-21 18:52:00 发表: 投了一篇，大修后接受，编辑审稿人效率高。, beContent=asp 2019-02-21 18:52:00 发表: 投了一篇，大修后接受，编辑审稿人效率高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6715139146, createdName=146715bem82(暂无昵称), createdTime=Tue Jan 07 00:00:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567070, encodeId=640556e07089, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，大修后接受，编辑审稿人效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJMC3tF03dm1t2TEOSN9Hiba2iagxaIW7O4RMcQJEESwLxBY5sgv2v1eyXOZd0e7xng6eLxqp7PoSAw/132, createdBy=c2d31631094, createdName=asp, createdTime=Thu Feb 21 18:52:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]

2020-01-07 146715bem82(暂无昵称)

我想问一下，送审的话，状态还是under review吗？还是说会改变？asp 2019-02-21 18:52:00 发表:
投了一篇，大修后接受，编辑审稿人效率高。

asp 2019-02-21 18:52:00 发表: 投了一篇，大修后接受，编辑审稿人效率高。

104 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583965, encodeId=9b6758396532, content=老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., beContent=nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c002335043, createdName=1227ad64m36暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582852, encodeId=6ac958285252, content=我想问一下，送审的话，状态还是under review吗？还是说会改变？asp 2019-02-21 18:52:00 发表: 投了一篇，大修后接受，编辑审稿人效率高。, beContent=asp 2019-02-21 18:52:00 发表: 投了一篇，大修后接受，编辑审稿人效率高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6715139146, createdName=146715bem82(暂无昵称), createdTime=Tue Jan 07 00:00:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567070, encodeId=640556e07089, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，大修后接受，编辑审稿人效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJMC3tF03dm1t2TEOSN9Hiba2iagxaIW7O4RMcQJEESwLxBY5sgv2v1eyXOZd0e7xng6eLxqp7PoSAw/132, createdBy=c2d31631094, createdName=asp, createdTime=Thu Feb 21 18:52:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]

2019-02-21 asp

审稿速度:1.0 | 投稿命中率:50.0
经验分享：投了一篇，大修后接受，编辑审稿人效率高。

170 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583965, encodeId=9b6758396532, content=老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., beContent=nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c002335043, createdName=1227ad64m36暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582852, encodeId=6ac958285252, content=我想问一下，送审的话，状态还是under review吗？还是说会改变？asp 2019-02-21 18:52:00 发表: 投了一篇，大修后接受，编辑审稿人效率高。, beContent=asp 2019-02-21 18:52:00 发表: 投了一篇，大修后接受，编辑审稿人效率高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6715139146, createdName=146715bem82(暂无昵称), createdTime=Tue Jan 07 00:00:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567070, encodeId=640556e07089, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，大修后接受，编辑审稿人效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJMC3tF03dm1t2TEOSN9Hiba2iagxaIW7O4RMcQJEESwLxBY5sgv2v1eyXOZd0e7xng6eLxqp7PoSAw/132, createdBy=c2d31631094, createdName=asp, createdTime=Thu Feb 21 18:52:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]

2020-02-13 1483b6d8m11暂无昵称

你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表:
我都这个状态2个月了，怎么办

173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办

214 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务